+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Specific IgE Blood Based Allergy Testing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Specific IgE Blood Based Allergy Testing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Specific IgE Blood Based Allergy Testing Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6080952
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The landscape of allergy diagnostics has evolved significantly over the past decade, driven by advances in immunoassay technologies, deeper clinical insights into immunoglobulin E (IgE) responses, and rising prevalence of allergic disorders worldwide. As clinicians and researchers strive to deliver more precise, personalized care, specific IgE blood based testing has emerged as an indispensable tool for both diagnostic clarity and therapeutic decision-making. This executive summary provides a comprehensive exploration of the critical factors shaping the market, from regulatory headwinds to technological breakthroughs, guiding stakeholders through a shifting terrain where speed, accuracy, and cost-effectiveness are paramount. By examining the forces reshaping supply chains, tariffs, and competitive dynamics, this analysis equips decision-makers with the actionable intelligence they need to capitalize on emerging opportunities and mitigate potential risks. Through in-depth insights on segmentation, regional trends, and key industry players, readers will gain a holistic view of the current environment, laying the foundation for strategic initiatives that align with evolving patient needs and healthcare priorities.

Transformative Shifts in the Landscape

Over the last several years, the allergy testing arena has experienced transformative shifts propelled by novel immunoassay platforms, a growing emphasis on precision medicine, and seamless integration of digital health tools. High-throughput chemiluminescence immunoassay systems now deliver panels of allergen-specific IgE results in a fraction of the time previously required, enabling clinicians to chart personalized management plans with unprecedented speed. Concurrently, innovations in fluorophore-based detection and multi-analyte serum arrays have elevated the sensitivity and specificity of diagnostic workflows. Digital connectivity between diagnostic instruments and electronic health records has streamlined data analytics, facilitating population-level insights that inform public health initiatives and product development. Moreover, the maturation of point-of-care testing devices is democratizing access, allowing community clinics and even home settings to perform reliable allergy screens. Collectively, these developments reflect a broader industry transformation, wherein rapid, data-driven decision-making intersects with patient-centric models of care to redefine how allergic diseases are detected and managed.

Cumulative Impact of United States Tariffs 2025

In 2025, the United States implemented new tariff measures on a range of imported diagnostic reagents and instrumentation, reshaping cost structures across the allergy testing ecosystem. These tariffs have translated into direct price increases for assay kits and high-precision analyzers, prompting manufacturers to reassess global supply chains and negotiate volume-based rebates with key distributors. The impact has rippled through diagnostic laboratories, academic research centers, and hospitals, where budget constraints now compel procurement teams to prioritize flexibility and value engineering. Some suppliers have shifted assembly operations to tariff-exempt jurisdictions, while others have diversified their component sourcing to mitigate duties. As stakeholders adapt to these cumulative effects, collaborative consortia are emerging to advocate for tariff relief and foster localized manufacturing initiatives. Ultimately, the 2025 tariff landscape has underscored the importance of supply chain resilience and strategic cost management in sustaining timely access to specific IgE blood testing resources.

Key Segmentation Insights

A granular examination of market segmentation reveals nuanced dynamics shaped by both clinical demand and technological adoption. Based on test type, the dual pathways of specific IgE assays and total IgE analyses cater to distinct diagnostic objectives: total IgE tests serve as broad indicators of atopic predisposition, whereas specific IgE panels pinpoint sensitization to precise allergens. Delving into allergy type segmentation, drug allergy assessments encompass a spectrum from aspirin and non-steroidal anti-inflammatory agents to penicillin and sulfa compounds, while food allergy evaluations cover common triggers such as egg, fish, milk, peanut, shellfish, soy, tree nuts, and wheat. Inhalant allergy diagnostics target environmental antigens including animal dander, dust mites, mold, and diverse pollen species, and insect allergy panels focus on ant, bee, and wasp venoms. Age group segmentation distinguishes adults from pediatric populations, reflecting age-related immune development and exposure patterns. End users span academic research institutes, diagnostic laboratories, and hospital networks, each with unique volume demands and workflow requirements. Product segmentation contrasts assay kits-formulated for standardized immunoassay protocols-with analyzer instruments that deliver automated, high-throughput processing. Application segments encompass academic research projects probing immunopathology, clinical diagnostics guiding patient management, and drug development pipelines evaluating immunogenicity. Finally, distribution channels range from hospital pharmacies to online and retail pharmacies, and technology segmentation covers chemiluminescence immunoassay, enzyme-linked immunosorbent assay, and fluoroenzyme immunoassay platforms. Understanding these interlocking segments empowers stakeholders to tailor strategies that address unmet clinical needs, optimize operational efficiencies, and drive future innovation.

Key Regional Insights

Regional variations exert a profound influence on allergy testing adoption, pricing structures, and regulatory environments. In the Americas, robust reimbursement frameworks and well-established laboratory networks sustain strong demand for both specific and total IgE testing, with private and public payers supporting broad diagnostic coverage. Conversely, Europe, the Middle East, and Africa present a mosaic of healthcare systems where pricing negotiations and centralized tenders shape procurement cycles; here, regional standards for in vitro diagnostic registration and shifting reimbursement policies can accelerate or impede market entry. Meanwhile, Asia-Pacific exhibits some of the fastest growth trajectories, driven by rising allergy prevalence, expanding middle-class healthcare access, and government initiatives to bolster diagnostic infrastructure. Local manufacturers in the Asia-Pacific region are increasingly competitive on price and are forging partnerships with global diagnostic firms to co-develop tailored solutions. In each region, understanding regulatory pathways, reimbursement landscapes, and laboratory accreditation requirements proves critical to unlocking sustainable expansion and aligning product portfolios with regional priorities.

Key Companies Insights

The competitive landscape is populated by a diverse array of specialized firms and industry leaders, each leveraging unique strengths to capture market share. Alergovita and Allergy Test Ltd focus on niche IgE panels and tailored service offerings for clinical research consortia, while ARUP Laboratories and Mayo Clinic Laboratories leverage their diagnostic expertise and high-capacity platforms to serve large healthcare networks. Established diagnostics giants such as bioMérieux SA, Danaher Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific Inc. continuously invest in next-generation assay development and strategic acquisitions to broaden their immunoassay portfolios. Regional innovators, including Dr. Fooke Laboratorien GmbH, EUROIMMUN Medizinische Labordiagnostika AG, HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, R-Biopharm AG, Stallergenes Greer, Tecan Group Ltd, and Theradiag SA, differentiate through proprietary reagent technologies, point-of-care devices, and integrated software solutions. Collectively, these players are forging collaborative research partnerships, optimizing manufacturing footprints to navigate tariff constraints, and pursuing digital health integrations to enhance data interoperability. As competition intensifies, value-driven offerings and strategic alliances will become increasingly pivotal to sustaining growth.

Actionable Recommendations for Industry Leaders

To thrive in the rapidly evolving specific IgE testing domain, industry leaders should adopt a multi-pronged strategy. First, investing in modular, high-throughput platforms that support both chemiluminescence and fluoroenzyme immunoassays can meet diverse laboratory requirements while reducing per-test costs through economies of scale. Second, forming cross-sector partnerships with clinical informatics providers will enable seamless integration of allergy test results into predictive analytics frameworks, unlocking new avenues for patient stratification and personalized therapy protocols. Third, diversifying manufacturing bases and establishing regional assembly hubs can mitigate the impact of tariffs and supply chain disruptions, ensuring consistent reagent availability. Fourth, expanding into emerging markets through tailored product bundles and flexible pricing models can accelerate adoption in regions with rising allergy burdens. Finally, committing to ongoing research collaborations with academic centers will drive innovations in multiplexed allergen panels and biomarker discovery, reinforcing leadership in precision diagnostics.

Conclusion

The current intersection of technological breakthroughs, shifting trade policies, and dynamic regional priorities marks a pivotal moment for the specific IgE blood based allergy testing sector. As laboratories and healthcare providers increasingly demand rapid, accurate, and cost-effective solutions, suppliers must align their innovation roadmaps with the evolving needs of clinicians, payers, and patients. Strategic agility in navigating tariff landscapes, coupled with purposeful investments in digital integration and R&D partnerships, will define market leadership over the coming years. By embracing segmentation insights and regional nuances, companies can deliver differentiated offerings that resonate with end users across diverse clinical settings. Ultimately, the ability to anticipate regulatory changes, optimize supply chains, and harness the power of data analytics will determine success in this high-stakes arena-where every incremental improvement in diagnostic precision translates into better patient outcomes and sustained competitive advantage.

Market Segmentation & Coverage

This research report categorizes the Specific IgE Blood Based Allergy Testing Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Specific IgE Tests
  • Total IgE Tests
  • Drug Allergies
    • Aspirin And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Penicillin
    • Sulfa Drugs
  • Food Allergies
    • Egg
    • Fish
    • Milk
    • Peanut
    • Shellfish
    • Soy
    • Tree Nuts
    • Wheat
  • Inhalant Allergies
    • Animal Dander
    • Dust Mites
    • Mold
    • Pollen
  • Insect Allergies
    • Ant
    • Bee
    • Wasp
  • Adults
  • Children
  • Academic Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Assay Kits
  • Instruments
  • Academic Research
  • Clinical Diagnostics
  • Drug Development
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Fluoroenzyme Immunoassay (FEIA)

This research report categorizes the Specific IgE Blood Based Allergy Testing Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Specific IgE Blood Based Allergy Testing Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Alergovita
  • Allergy Test Ltd
  • ARUP Laboratories
  • bioMérieux SA
  • Danaher Corporation
  • Dr. Fooke Laboratorien GmbH
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HYCOR Biomedical
  • Lincoln Diagnostics Inc.
  • Mayo Clinic Laboratories
  • Omega Diagnostics Group PLC
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • R-Biopharm AG
  • Roche Diagnostics
  • Siemens Healthineers
  • Stallergenes Greer
  • Tecan Group Ltd
  • Theradiag SA
  • Thermo Fisher Scientific Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Specific IgE Blood Based Allergy Testing Market, by Test Type
8.1. Introduction
8.2. Specific IgE Tests
8.3. Total IgE Tests
9. Specific IgE Blood Based Allergy Testing Market, by Allergy Type
9.1. Introduction
9.2. Drug Allergies
9.2.1. Aspirin And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
9.2.2. Penicillin
9.2.3. Sulfa Drugs
9.3. Food Allergies
9.3.1. Egg
9.3.2. Fish
9.3.3. Milk
9.3.4. Peanut
9.3.5. Shellfish
9.3.6. Soy
9.3.7. Tree Nuts
9.3.8. Wheat
9.4. Inhalant Allergies
9.4.1. Animal Dander
9.4.2. Dust Mites
9.4.3. Mold
9.4.4. Pollen
9.5. Insect Allergies
9.5.1. Ant
9.5.2. Bee
9.5.3. Wasp
10. Specific IgE Blood Based Allergy Testing Market, by Age Group
10.1. Introduction
10.2. Adults
10.3. Children
11. Specific IgE Blood Based Allergy Testing Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals
12. Specific IgE Blood Based Allergy Testing Market, by Product
12.1. Introduction
12.2. Assay Kits
12.3. Instruments
13. Specific IgE Blood Based Allergy Testing Market, by Application
13.1. Introduction
13.2. Academic Research
13.3. Clinical Diagnostics
13.4. Drug Development
14. Specific IgE Blood Based Allergy Testing Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacies
14.3. Online Pharmacies
14.4. Retail Pharmacies
15. Specific IgE Blood Based Allergy Testing Market, by Technology
15.1. Introduction
15.2. Chemiluminescence Immunoassay (CLIA)
15.3. Enzyme-Linked Immunosorbent Assay (ELISA)
15.4. Fluoroenzyme Immunoassay (FEIA)
16. Americas Specific IgE Blood Based Allergy Testing Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Specific IgE Blood Based Allergy Testing Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Specific IgE Blood Based Allergy Testing Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Alergovita
19.3.2. Allergy Test Ltd
19.3.3. ARUP Laboratories
19.3.4. bioMérieux SA
19.3.5. Danaher Corporation
19.3.6. Dr. Fooke Laboratorien GmbH
19.3.7. EUROIMMUN Medizinische Labordiagnostika AG
19.3.8. HYCOR Biomedical
19.3.9. Lincoln Diagnostics Inc.
19.3.10. Mayo Clinic Laboratories
19.3.11. Omega Diagnostics Group PLC
19.3.12. PerkinElmer Inc.
19.3.13. Quest Diagnostics Incorporated
19.3.14. R-Biopharm AG
19.3.15. Roche Diagnostics
19.3.16. Siemens Healthineers
19.3.17. Stallergenes Greer
19.3.18. Tecan Group Ltd
19.3.19. Theradiag SA
19.3.20. Thermo Fisher Scientific Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET MULTI-CURRENCY
FIGURE 2. SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 22. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY SPECIFIC IGE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TOTAL IGE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ASPIRIN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY SULFA DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY EGG, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY MILK, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PEANUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY SHELLFISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TREE NUTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY WHEAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ANIMAL DANDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DUST MITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY MOLD, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY BEE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY WASP, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY (CLIA), BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FLUOROENZYME IMMUNOASSAY (FEIA), BY REGION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 98. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 99. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 100. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 101. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. CANADA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 111. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 112. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 114. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. MEXICO SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 159. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 160. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 161. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 162. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 163. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. CHINA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 170. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 171. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 172. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 173. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 174. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 175. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 176. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. INDIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 194. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 195. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 196. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 197. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 198. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 199. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. JAPAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SINGAPORE SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SOUTH KOREA SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. TAIWAN SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 266. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 267. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 268. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 269. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 270. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 271. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 272. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. THAILAND SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY DRUG ALLERGIES, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY FOOD ALLERGIES, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INHALANT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM SPECIFIC IGE BLOOD BASED ALLERGY TESTING MARKET SIZE, BY INSECT ALLERGIES, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM SPECIFIC IGE BLOOD BASED A

Companies Mentioned

  • Alergovita
  • Allergy Test Ltd
  • ARUP Laboratories
  • bioMérieux SA
  • Danaher Corporation
  • Dr. Fooke Laboratorien GmbH
  • EUROIMMUN Medizinische Labordiagnostika AG
  • HYCOR Biomedical
  • Lincoln Diagnostics Inc.
  • Mayo Clinic Laboratories
  • Omega Diagnostics Group PLC
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • R-Biopharm AG
  • Roche Diagnostics
  • Siemens Healthineers
  • Stallergenes Greer
  • Tecan Group Ltd
  • Theradiag SA
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Single-Molecule Immunoassay Instrument Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Single-Molecule Immunoassay Instrument Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global, United States Global, United States
From
IgE Allergy Blood Tests Market by Product Type, Test Type, Application, End User, Allergen Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

IgE Allergy Blood Tests Market by Product Type, Test Type, Application, End User, Allergen Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Immunoglobulin E (IgE) Allergy Blood Tests Market Report 2025 - Product Image

Immunoglobulin E (IgE) Allergy Blood Tests Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Allergy Diagnostics - Global Strategic Business Report - Product Image

Allergy Diagnostics - Global Strategic Business Report

  • Report
  • 638 Pages
  • Global
From
House Dust Mite Allergy Global Market Opportunities and Strategies to 2033 - Product Image

House Dust Mite Allergy Global Market Opportunities and Strategies to 2033

  • Report
  • 278 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.